Spyre Therapeutics (SYRE) Q1 2019 Earnings

7MayExpected
Q2 2018
Q3 2018
Q4 2018
Q1 2019
-15.5
-10.45
-5.41
-0.36

Details

Expected EPS
-0.55
Actual EPS
-14.75
Surprise EPS
-14.2
Surprise Percent
+2,581.82%

Description

Spyre Therapeutics (SYRE) has reported earnings of -14.75 per share for Q1 2019.

0 Comments

Share your thoughts